LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Condition(s):Lung Cancer; Non-Small Cell Lung Cancer; Adenocarcinoma of LungLast Updated:March 26, 2024Terminated
Hide Studies Not Open or Pending
Condition(s):Lung Cancer; Non-Small Cell Lung Cancer; Adenocarcinoma of LungLast Updated:March 26, 2024Terminated
Condition(s):Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Multiple MyelomaLast Updated:March 26, 2024Active, not recruiting
Condition(s):Lung Adenocarcinoma; EGFR Activating MutationLast Updated:October 15, 2019Completed
Condition(s):Ovarian Cancer; Lung AdenocarcinomaLast Updated:March 4, 2024Recruiting
Condition(s):Lung Adenocarcinoma; Lymph Node MetastasisLast Updated:September 11, 2023Recruiting
Condition(s):Cancer: Recurrent and/or Metastatic Solid TumoursLast Updated:July 14, 2022Recruiting
Condition(s):Lung Adenocarcinoma; Lung NeoplasmsLast Updated:March 26, 2024Completed
Condition(s):Non-small Cell Lung Cancer MetastaticLast Updated:August 7, 2017Unknown status
Condition(s):Lung Cancer; Lung Diseases; Adenocarcinoma of LungLast Updated:February 18, 2022Completed
Condition(s):Lung Adenocarcinoma; Lung Adenosquamous Carcinoma; Malignant Pericardial Effusion; Malignant Pleural Effusion; Minimally Invasive Lung Adenocarcinoma; Stage IIIB Lung Non-Small Cell Cancer AJCC v7; Stage IV Lung Non-Small Cell Cancer AJCC v7Last Updated:August 7, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.